2020 Trends In Pharma Asset Licensing And Deal Terms: A Survey Of Key Decision-Makers Lain Anderson TJ Bilodeau Read more
Related Practice Life Sciences & Pharma In this article, we describe some key drivers of asset value, as well as areas of alignment and divergence between parties on deal expectations. 01052021090143
Executive Insights Life Sciences & Pharma Advanced In Vitro Models: Opportunities and Challenges for US Drug Development May 7, 2025
Case Study Life Sciences & Pharma Optimizing Four-Wall DC Operations for a Pharmaceutical Distributor March 27, 2025 After years of stable but stagnant warehouse performance, a major pharmaceutical distributor sought to modernize its technology infrastructure to boost…
Executive Insights Digital Your AI Transformation Needs a Different Leadership Approach March 7, 2025
Published Articles Digital It’s time to go all-in on digital: Four key strategies of successful leaders November 7, 2024
Article Healthcare Services Healthcare Crossroads? The 2024 Election and What’s Really at Stake October 29, 2024
